Liyam Laraba et al. reported that genetic ablation of the Hippo effectors YAP and TAZ and application of TEAD palmitoylation inhibitors suppressed the Hippo signaling pathway and regressed schwannoma and meningioma tumor growth both in-vivo and in-vitro [30]. The gene discussed is YAP1; the disease is schwannoma.